Euda Health Holdings Stock Performance
| EUDA Stock | 3.32 0.10 2.92% |
On a scale of 0 to 100, EUDA Health holds a performance score of 4. The firm shows a Beta (market volatility) of -0.36, which means possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning EUDA Health are expected to decrease at a much lower rate. During the bear market, EUDA Health is likely to outperform the market. Please check EUDA Health's semi deviation, jensen alpha, maximum drawdown, as well as the relationship between the coefficient of variation and sortino ratio , to make a quick decision on whether EUDA Health's price patterns will revert.
Risk-Adjusted Performance
Soft
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in EUDA Health Holdings are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unfluctuating fundamental indicators, EUDA Health sustained solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return (2.92) | Five Day Return 10.67 | Year To Date Return (28.29) | Ten Year Return (65.60) | All Time Return (65.60) |
1 | Should I average down on EUDA Health Holdings Limited Equity Warrant stock - Rate Cut Risk Managed Investment Entry Signals - theviewers.co.kr | 08/21/2025 |
2 | Strategies to average down on EUDA Health Holdings Limited Equity Warrant - Quarterly Profit Summary High Conviction Buy Zone Picks - Newser | 09/02/2025 |
3 | EUDA Strategically Expands into T-Cell Immunotherapy Strengthening Its Stem Cell Therapy Portfolio | 09/04/2025 |
4 | RSI Suggests Rebound May Be Near in EUDA Health Holdings Limited Equity Warrant - July 2025 Big Picture Proven Capital Preservation Methods - beatles.ru | 09/08/2025 |
5 | Take Profit Is EUDA Health Holdings Limited a cyclical or defensive stock - 2025 Big Picture Community Verified Trade Alerts - | 09/16/2025 |
6 | Surprises Report Is now the right time to enter EUDA Health Holdings Limited Equity Warrant - 2025 Earnings Surprises Free Reliable Trade Execution Plans - khod... | 09/19/2025 |
7 | How EUDA Health Holdings Limited Equity Warrant stock performs in interest rate cycles - Gap Down Long-Term Capital Growth Strategies - newser.com | 09/26/2025 |
8 | How EUDA Health Holdings Limited Equity Warrant stock performs in interest rate cycles - Weekly Risk Summary Weekly Setup with High ROI Potential - newser.com | 09/29/2025 |
9 | EUDA Health Holdings Amends Convertible Note Agreement - TipRanks | 10/03/2025 |
10 | Published on 2025-10-17 225621 - Trung tm D bo KTTV quc gia | 10/17/2025 |
| Begin Period Cash Flow | 197.6 K | |
| Total Cashflows From Investing Activities | -147.8 K |
EUDA Health Relative Risk vs. Return Landscape
If you would invest 309.00 in EUDA Health Holdings on July 20, 2025 and sell it today you would earn a total of 23.00 from holding EUDA Health Holdings or generate 7.44% return on investment over 90 days. EUDA Health Holdings is currently generating 0.4493% in daily expected returns and assumes 8.4723% risk (volatility on return distribution) over the 90 days horizon. In different words, 75% of stocks are less volatile than EUDA, and 91% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
EUDA Health Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for EUDA Health's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as EUDA Health Holdings, and traders can use it to determine the average amount a EUDA Health's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.053
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | EUDA | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 8.47 actual daily | 75 75% of assets are less volatile |
Expected Return
| 0.45 actual daily | 9 91% of assets have higher returns |
Risk-Adjusted Return
| 0.05 actual daily | 4 96% of assets perform better |
Based on monthly moving average EUDA Health is performing at about 4% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of EUDA Health by adding it to a well-diversified portfolio.
EUDA Health Fundamentals Growth
EUDA Stock prices reflect investors' perceptions of the future prospects and financial health of EUDA Health, and EUDA Health fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on EUDA Stock performance.
| Return On Asset | -0.64 | ||||
| Profit Margin | 0.05 % | ||||
| Operating Margin | (0.37) % | ||||
| Current Valuation | 78.65 M | ||||
| Shares Outstanding | 37.77 M | ||||
| Price To Sales | 25.03 X | ||||
| Revenue | 4.01 M | ||||
| Gross Profit | 1.16 M | ||||
| EBITDA | (17.42 M) | ||||
| Net Income | (17.6 M) | ||||
| Total Debt | 1.27 M | ||||
| Book Value Per Share | (0.10) X | ||||
| Cash Flow From Operations | (2.03 M) | ||||
| Earnings Per Share | 0.02 X | ||||
| Market Capitalization | 129.17 M | ||||
| Total Asset | 1.73 M | ||||
| Retained Earnings | (50.1 M) | ||||
| Working Capital | (3.38 M) | ||||
About EUDA Health Performance
By analyzing EUDA Health's fundamental ratios, stakeholders can gain valuable insights into EUDA Health's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if EUDA Health has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if EUDA Health has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 16.66 | 15.83 | |
| Return On Tangible Assets | (11.03) | (10.48) | |
| Return On Capital Employed | 7.19 | 7.55 | |
| Return On Assets | (8.88) | (8.43) | |
| Return On Equity | 6.02 | 6.32 |
Things to note about EUDA Health Holdings performance evaluation
Checking the ongoing alerts about EUDA Health for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for EUDA Health Holdings help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| EUDA Health Holdings had very high historical volatility over the last 90 days | |
| EUDA Health Holdings has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 4.01 M. Net Loss for the year was (17.6 M) with profit before overhead, payroll, taxes, and interest of 1.16 M. | |
| EUDA Health generates negative cash flow from operations | |
| About 50.0% of the company shares are held by company insiders | |
| Latest headline from news.google.com: Published on 2025-10-17 225621 - Trung tm D bo KTTV quc gia |
- Analyzing EUDA Health's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether EUDA Health's stock is overvalued or undervalued compared to its peers.
- Examining EUDA Health's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating EUDA Health's management team can have a significant impact on its success or failure. Reviewing the track record and experience of EUDA Health's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of EUDA Health's stock. These opinions can provide insight into EUDA Health's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for EUDA Stock analysis
When running EUDA Health's price analysis, check to measure EUDA Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy EUDA Health is operating at the current time. Most of EUDA Health's value examination focuses on studying past and present price action to predict the probability of EUDA Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move EUDA Health's price. Additionally, you may evaluate how the addition of EUDA Health to your portfolios can decrease your overall portfolio volatility.
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |